A specialty pharmaceutical company focused on therapies for maternal health, anemia, and rare diseases. Its portfolio historically included Feraheme, an intravenous iron therapy for iron deficiency anemia, and Makena, a treatment aimed at reducing the risk of preterm birth. Investors followed the co...
1 member of Congress has disclosed 2 trades in AMAg Pharmaceuticals, Inc. (AMAG), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 1 sale. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2015-05-27 | Thomas MacArthur | sell | $1K – $15K |
| 2015-05-20 | Thomas MacArthur | buy | $1K – $15K |